In this Section |
229439 Acceptability of routine Trichomonas screening for incarcerated womenTuesday, November 9, 2010
: 12:50 PM - 1:10 PM
BACKGROUND: Trichomonas is the most prevalent curable sexually transmitted infection in the United States. It has been associated with preterm delivery, infertility, HIV and cervical neoplasia. Incarcerated women exhibit a higher prevalence of Trichomonas (37%) than reproductive age women in the general U.S. population (3.1%). Rates of testing remain low despite the potential complications. OBJECTIVE: We sought to determine the acceptability of testing for Trichomonas for women entering jail by a self-obtained vaginal swab. METHODS: A random sample of 118 women entering the Rhode Island Department of Corrections was recruited. Women were instructed on how to collect self-obtained vaginal samples and completed a satisfaction survey after getting the samples. RESULTS: When asked their agreement with the statement, “It was easy to collect the vaginal swab”, 55% of participants indicated “very strong agreement” and 18.3% indicated “moderate agreement”. Regarding preferred specimen collection method, 63.5% selected self-obtained vaginal swab, 23.8% designated pelvic exam and 12.7% opted for urine sample. CONCLUSIONS: Incarcerated women, who exhibit a high STD incidence rate overall, find self-obtained vaginal swabs acceptable to test for STDs. Routine screening of the incarcerated population has the potential to improve Trichomonas detection and treatment rates dramatically. This population is especially important to target not only due to a high burden of disease, but also high rates of associated illnesses, including HIV and cervical neoplasia.
Learning Areas:
Public health or related researchLearning Objectives: Keywords: STD, Prison
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I serve as the primary physician at the Women's Division of the Rhode Island Department of Corrections. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4221.0: The health of incarcerated women: A matter of social justice
|